Results 51 to 60 of about 7,356,812 (159)
Are Myeloproliferative Neoplasms‐Unclassifiable Really Unclassifiable?
eJHaem, Volume 7, Issue 2, April 2026.
Giovanni Barosi +2 more
wiley +1 more source
Cancer Medicine, Volume 13, Issue 6, March 2024.Abstract Background of the study AML classification tools have been developed to stratify the risk at AML diagnosis. There is a need to evaluate these tools in the current therapeutic era. Cohort characteristics In this retrospective study, we compared five classifiers: ELN 2017, ELN 2022, ALFA classifier, Papaemmanuil et al.
Alexandre Iat +12 more
wiley +1 more source
Vaccine Misinformation: Statement by WHO Director-General on Facebook and Instagram
Эпидемиология и вакцинопрофилактика, 2019 .
article Editorial
doaj
International Journal of Methods in Psychiatric Research, Volume 33, Issue 1, March 2024.Abstract Background The abbreviated version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) psychosis screen tends to yield high prevalence in online samples. Psychotic Experiences (PE) may not necessarily indicate current or imminent psychopathology; however, distressing PE appear to be more clinically ...
Hans Oh +5 more
wiley +1 more source
Global organ shortage: an analysis of national self‑sufficiency strategies
Вестник трансплантологии и искусственных органов, 2020 From the standpoint of socio-humanitarian knowledge, the paper analyzes the problem of global organ shortage. The basic ideas of the international medical community about organ shortage and the main proposals for overcoming it are considered.
O. N. Reznik, D. V. Mikhel
doaj +1 more source
Epilepsia Open, Volume 9, Issue 1, Page 77-83, February 2024.Abstract The International League Against Epilepsy (ILAE)/International Bureau for Epilepsy (IBE)/World Health Organization (WHO) Global Campaign Against Epilepsy was launched in Geneva and Dublin in the summer of 1997. The second phase of the Campaign was launched by a major event in Geneva, led by WHO Director General Dr.
Edward H. Reynolds
wiley +1 more source
International Journal of Energy Research, Volume 2024, Issue 1, 2024.In March 2020, the World Health Organization (WHO) proclaimed the novel coronavirus 2019 (COVID‐19) a global pandemic with no therapy/vaccination or universally accepted therapeutic modalities. This resulted in the implementation of containment measures such as lockdowns, which hindered economic activities and, as a result, hampered global demand ...
Mwewa Chikonkolo Mwape +4 more
wiley +1 more source
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
ClinicoEconomics and Outcomes Research, 2023 Sarfaraz K Niazi College of Pharmacy, University of Illinois, Chicago, IL, 60612, USACorrespondence: Sarfaraz K Niazi, Tel +1-312-297-0000, Email niazi@niazi.comAbstract: Almost two decades since biosimilars arrived, we still await their broader adoption,
Niazi SK
doaj
Cardiovascular Diseases Among Indian Older Adults: A Comprehensive Review
Cardiovascular Therapeutics, Volume 2024, Issue 1, 2024.Cardiovascular diseases (CVDs) constitute an important cause of morbidity and mortality globally, and India is no exception to this trend. With the ongoing aging of the population in India, there is a notable surge in the prevalence and impact of CVDs among older adults.
Bisma Jan +6 more
wiley +1 more source
Pakistan Armed Forces Medical Journal, 2018 Objective: To investigate the pediatric group expression of β-catenin and pattern of immunohistochemistry in medulloblastoma patients following WHO classification. Study Design: Cross-sectional descriptive study.
Majid Latif +3 more
doaj